Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > C. Mark Schneyer > Profile

C. Mark Schneyer

Affiliations

  • Evp, Chief Financial Officer at Acadia Pharmaceuticals Inc (ACAD), 2024-11-20
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Acadia Pharmaceuticals Inc
 ACAD $16.81 10,259 53,302 2024-11-19 Filing
Acadia Pharmaceuticals Inc
 ACAD $15.28 9,733 43,735 2024-08-19 Filing
Acadia Pharmaceuticals Inc
 ACAD $14.79 975 34,564 2024-06-10 Filing
Acadia Pharmaceuticals Inc
 ACAD $16.94 3,503 32,053 2024-05-02 Filing
Acadia Pharmaceuticals Inc
 ACAD $17.87 2,716 28,742 2024-04-08 Filing